Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-80P, also known as "RNA, U4 small nuclear 80, pseudogene," is a non-coding RNA pseudogene in the human genome. It is a sequence homologous to the functional U4 small nuclear RNA (snRNA) gene but contains mutations or structural features that render it non-functional. The U4 snRNA is an essential component of the major spliceosome involved in pre-mRNA splicing, but RNU4-80P does not produce a functional RNA product and is not known to participate in any biological pathways or disease mechanisms. The existence of U4 snRNA pseudogenes such as RNU4-80P likely reflects reverse transcription and integration events in evolution, but there is no evidence that RNU4-80P itself has any transcriptional activity or clinical relevance as a therapeutic target[1][5]. Key clarifications: - Canonical naming: The target is a pseudogene, not a functional snRNA gene, receptor, enzyme, transporter, or other therapeutic target class. - Therapeutic relevance: No evidence exists that RNU4-80P serves as a drug target, biomarker, or disease-modifying gene; only its functional homologs such as RNU4-2 (U4 snRNA) are disease-relevant and have pathogenic variants associated with neurodevelopmental disorders[4][5]. - Correction: If the query intended to reference a functional U4 snRNA (like RNU4-2), use "U4 small nuclear RNA (RNU4-2)" instead. If the intent was for a therapeutic or clinical target, RNU4-80P is incorrect and not suitable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U4 small nuclear RNA, pseudogene 80 (RNU4-80P).